The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/4762
StudyName: A Phase II Study of AZD4877 (a Novel Anti-mitotic  DRKS00004052
Date of export from the portal: 02.07.2020
Date of Upload / last change: 27.03.2014
License: Creative Commons BY 4.0

----

Description: 
The purpose of this Phase II study is to determine if AZD4877, an experimental drug that is a novel anti-mitotic agent (Eg5 or Kinesin Spindle Protein inhibitor that interferes with tumor cell division leading to tumor growth), can reduce tumor sizes in patients with bladder cancer

see http://clinicaltrials.gov/ct2/show/study/NCT00661609
